U.S. FDA classifies recall of GE's ventilator batteries as most serious
Reuters
Published Jun 28, 2022 12:50PM ET
(Reuters) - U.S. health regulators on Tuesday classified the recall of some backup batteries of GE Healthcare's ventilators, which the company had initiated in mid-April, as the most serious type, saying that their use could lead to injuries or death.
The CARESCAPE R860 ventilator's backup batteries, including replacement backup batteries, were recalled as they were running out earlier-than-expected, which could cause the device to shut down preventing the patient from receiving breathing support, the U.S. Food and Drug Administration said.
The CARESCAPE R860 ventilators use the main power via a wall plug to operate and the device's backup battery is meant to keep it running in situations such as patient transport.
GE Healthcare, the medical device making arm of General Electric (NYSE:GE), had initiated the recall of 4,222 of its ventilator batteries distributed between April 2, 2019, and April 18, 2022. (https://
There have been 1,553 complaints and one injury associated with the use of the device, the FDA said.
On Tuesday, Philips said independent tests on ventilators that the Dutch company recalled last year because of possible health risks showed the problems were almost exclusively caused by unauthorized cleaning products.
The Amsterdam-based company's recall was launched amid concerns that a type of foam used in the devices could deteriorate and become toxic.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.